AquaLite(R) Technology from SeaLite Sciences, Inc.

Researchers are always on the lookout for more sensitive conjugates for use in bioassays. The bioluminescent photoprotein aequorin is proving to be a useful alternative to traditional enzyme tags in ELISA-type immunoassays. SeaLite Sciences, Inc., of Bogart, Ga., manufactures a fully active, recombinant form of aequorin under the trademark AquaLite and sells a number of different useful derivatives and conjugates, including AquaLite® Biotin and AquaLite® Streptavidin. Aequorin is a 22

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Researchers are always on the lookout for more sensitive conjugates for use in bioassays. The bioluminescent photoprotein aequorin is proving to be a useful alternative to traditional enzyme tags in ELISA-type immunoassays. SeaLite Sciences, Inc., of Bogart, Ga., manufactures a fully active, recombinant form of aequorin under the trademark AquaLite and sells a number of different useful derivatives and conjugates, including AquaLite® Biotin and AquaLite® Streptavidin.

Aequorin is a 22 kDa protein complex from the jellyfish Aequorea victoria; it contains bound oxygen, the luciferin coelenterazine, and three calcium binding sites. Upon addition of calcium ions, aequorin undergoes conformational changes that result in the oxidation of coelenterazine by the protein-bound oxygen. As diagrammed below, the energy from this oxidation reaction is released as a flash of blue light, centered at 469 nm.

Calcium Light Production from Aqualite® Bioluminescent assays can be adapted for use in many different research applications. David Smith, ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies